ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AGEN vs SABS // ENTERPRISE SCALE & MARKET CAP

Agenus Inc. (NASDAQ) VS. SAB Biotherapeutics Inc. (NASDAQ) • 15-METRIC TALLY: AGEN 1 — SABS 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: AGEN
market-cap
$320.2M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGEN VS. SABS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AGEN SABS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -27.40% -7.60 SABS /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -24.11% -15.55% -8.56 SABS /fcf-yield <GO>
Operating Margin -17.70% — — TIE /operating-margins <GO>
Net Profit Margin -2.70% — — TIE /net-margins <GO>
Revenue Growth (YoY) 10.40% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 7.07 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.7 60.2 -13.44 SABS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 20.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $320.2M $293.9M $26.3M AGEN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AGEN REV SABS REV AGEN GROSS % SABS GROSS % AGEN FCF SABS FCF
FY 2025 $114.2M $0 98.0% — -$77.2M -$45.7M
FY 2024 $103.5M $1.3M 98.0% — -$158.9M -$34.6M
FY 2023 $156.3M $2.2M — — -$224.2M -$25.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGEN // BETA —
SABS // BETA —